FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
3.040
-0.140 (-4.40%)
At close: Nov 4, 2024, 4:00 PM
3.114
+0.074 (2.43%)
After-hours: Nov 4, 2024, 5:59 PM EST
FibroBiologics Employees
FibroBiologics had 10 employees as of December 31, 2023. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change (1Y)
3
Growth (1Y)
42.86%
Revenue / Employee
n/a
Profits / Employee
-$1,947,100
Market Cap
107.19M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10 | 3 | 42.86% |
Dec 31, 2022 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Karyopharm Therapeutics | 325 |
Veru Inc. | 189 |
Cibus | 183 |
Quantum-Si incorporated | 159 |
Allakos | 131 |
Myomo | 106 |
Invivyd | 95 |
Eupraxia Pharmaceuticals | 29 |
FBLG News
- 6 days ago - FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology - GlobeNewsWire
- 7 days ago - FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024 - GlobeNewsWire
- 17 days ago - FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases - GlobeNewsWire
- 19 days ago - FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office - GlobeNewsWire
- 24 days ago - FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 5 weeks ago - FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa - GlobeNewsWire
- 6 weeks ago - FibroBiologics Engages Southern Star Research as CRO in Australia - GlobeNewsWire
- 7 weeks ago - FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology - GlobeNewsWire